Beth Ford

From WikiMD's WELLNESSPEDIA

Beth Ford is an American business executive who currently serves as the President and Chief Executive Officer (CEO) of Land O'Lakes, a major American agribusiness and food company. She is recognized for being the first openly gay woman to lead a Fortune 500 company.

Early Life and Education[edit]

Beth Ford was born and raised in Sioux City, Iowa. She earned her Bachelor's degree in Business from Iowa State University and later pursued an MBA from Columbia University Business School.

Career[edit]

Ford began her career in the late 1980s, working for companies such as Mobil Corporation, PepsiCo, and Scholastic. Her roles varied from supply chain operations to executive leadership.

In 2012, Ford joined Land O'Lakes, initially serving as the head of the company's supply chain and operations. In 2018, she was promoted to the position of CEO, making history as the first openly gay woman to lead a Fortune 500 company.

Personal Life[edit]

Ford is openly gay and has been a vocal advocate for LGBTQ+ rights in the corporate world. She lives with her wife and their three children.

Recognition[edit]

Ford has been recognized for her leadership and advocacy. In 2020, she was named one of Forbes' "World's 100 Most Powerful Women". She has also been honored by Outstanding 50 LGBT+ Leaders and Fortune's "Most Powerful Women" list.

See Also[edit]

This article is a stub related to food. You can help WikiMD by expanding it!


Beth Ford gallery[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Beth_Ford&oldid=6418049"